Molecular Testing to Identify Solid Tumor Molecular Markers - a podcast by CAP

Precision oncology in the treatment of solid tumors is a rapidly growing field which involves testing for molecular biomarkers. Molecular biomarkers can be used to confirm a diagnosis, provide prognostic information, and select targeted therapies. Pathologists need a working knowledge of these biomarkers and assays used for their evaluation to optimize patient care, explains Jennifer Yoest, MD, FCAP, a pathologist at UH Cleveland Medical Center, in this CAPcast.

Dr. Yoest, who led the development of a Clinical Pathology Improvement Program course on this topic (https://capatholo.gy/3187OsM), will also discuss how this knowledge will also help pathologists triage specimens and prioritize testing in situations where limited tissue is available, which is also known as tissue stewardship.

Further episodes of CAPcast from the College of American Pathologists

Further podcasts by CAP

Website of CAP